Stock 0GY1 SWEDISH ORPHAN BIOVITRUM
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar SWEDISH ORPHAN BIOVITRUM London S.E.

Equities

0GY1

End-of-day quote London S.E.
Other stock markets
- SEK - Intraday chart for SWEDISH ORPHAN BIOVITRUM
06-19 Sobi Wins EU Approval for Hemophilia A Drug Altuvoct MT
06-19 European Commission Grants Sobi® Marketing Authorisation for Altuvoct? for Treatment of Haemophilia A CI

Chart calendar SWEDISH ORPHAN BIOVITRUM

0a267a7d2333a6b7a.cL6BwYBhoZCAkYExAjuHa1IrUYda7_XMGycD9Qx5pVo.R93tprcX5unJpthpSA_dUxAfM9AOqI-ZWBFylmcI9y0G0OSqtirS3cil2A~f6d9b5988d517c10249b85ab66f546b6

Upcoming events on SWEDISH ORPHAN BIOVITRUM

15/07/2024 Q2 2024 Earnings Release
23/10/2024 Q3 2024 Earnings Release
04/02/2025 Q4 2024 Earnings Release
23/04/2025 Q1 2025 Earnings Release (Projected)
21/07/2025 Q2 2025 Earnings Release (Projected)
22/10/2025 Q3 2025 Earnings Release (Projected)
04/02/2026 Q4 2025 Earnings Release (Projected)

Past events on SWEDISH ORPHAN BIOVITRUM

03/06/2024 15:00 American Society of Clinical Oncology Meeting - Poster No:6577
03/06/2024 15:00 American Society of Clinical Oncology Meeting - Poster No:6578
03/06/2024 15:00 American Society of Clinical Oncology Meeting - Poster No:6579
14/05/2024 14:00 Annual General Meeting
25/04/2024 15:00 Q1 2024 Earnings Call
25/04/2024 07:00 Q1 2024 Earnings Release
08/02/2024 13:00 Q4 2023 Earnings Call
08/02/2024 09:22 Q4 2023 Earnings Release
08/12/2023 American Society of Hematology Meeting
01/11/2023 American Society of Nephrology Kidney Week Meeting
30/10/2023 12:00 Q3 2023 Earnings Call
30/10/2023 07:37 Q3 2023 Earnings Release
18/09/2023 14:00 Investor Meeting - KOL
27/08/2023 Rights Issue: 1 new share @ 142 SEK for 7 existing shares
15/08/2023 09:00 Extraordinary Shareholders Meeting
19/07/2023 14:30 Investor Meeting - Key Opinion Leader
18/07/2023 12:00 Q2 2023 Earnings Call
18/07/2023 09:39 Q2 2023 Earnings Release
28/06/2023 Investor Meeting - Stiefel
24/06/2023 International Society on Thrombosis and Haemostasis Meeting

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million SEK		Released
Forecast
Spread 		14 248
14 210
0.26%		15 261
15 155
0.7%		15 529
15 338
1.24%		18 790
18 363
2.32%		22 123
21 968
0.71%
24 620

EBITDA
Million SEK		Released
Forecast
Spread 		6 121
6 302
-2.87%		6 830
6 196
10.24%		5 740
5 466
5.01%		6 758
6 072
11.3%		7 676
7 475
2.69%
8 972

EBIT
Million SEK		Released
Forecast
Spread 		4 533
4 774
-5.04%		4 818
4 110
17.24%		3 733
3 539
5.47%		4 488
4 051
10.78%		4 485
4 437
1.07%
5 326

Earnings before Tax (EBT)
Million SEK		Released
Forecast
Spread 		4 247
4 540
-6.46%		4 217
3 562
18.38%		3 295
3 108
6.03%		3 321
3 270
1.56%		2 954
3 399
-13.09%
4 299

Net income
Million SEK		Released
Forecast
Spread 		3 304
3 556
-7.08%		3 245
2 743
18.31%		2 679
2 375
12.8%		2 638
2 620
0.69%		2 409
2 695
-10.6%
3 442

EPS
SEK		Released
Forecast
Spread 		11,2
12,1
-6.99%		10,9
9,25
17.9%		9,03
8,01
12.75%		8,84
8,84
0.01%		7,39
8,46
-12.69%
10,3

Announcement Date13/02/2018/02/2110/02/2208/02/2308/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million SEK		Released
Forecast
Spread 		4 925
4 470
10.17%		3 876
3 533
9.72%		3 999
3 905
2.41%		5 991
5 512
8.7%		5 239
5 142
1.89%		4 872
4 403
10.66%		5 168
4 628
11.66%		6 844
6 735
1.62%		6 256
5 805
7.77%
5 125


6 112


7 323


6 538


6 034

EBITDA
Million SEK		Released
Forecast
Spread 		1 461
1 608
-9.17%		997
854
16.69%		1 278
1 170
9.27%		2 493
2 298
8.49%		2 159
1 768
22.11%		1 286
1 079
19.18%		1 585
1 122
41.3%		2 645
2 681
-1.34%		2 377
2 015
17.97%
1 390


2 041


3 195


2 704


2 448

EBIT
Million SEK		Released
Forecast
Spread 		1 437
1 169
22.96%		423
376
12.36%		699
739
-5.42%		1 916
1 764
8.6%		1 495
1 208
23.75%		413
531
-22.27%		547
441
23.98%		1 691
1 970
-14.16%		1 468
1 114
31.78%
516


1 452


2 169


1 765


1 509

Earnings before Tax (EBT)
Million SEK		Released
Forecast
Spread 		674
1 061
-36.48%		317
278
13.96%		564
495
13.99%		1 766
1 689
4.57%		1 325
1 032
28.33%		275
329
-16.51%		116
239
-51.51%		1 237
1 804
-31.41%		982
811
21.04%
233


929


2 045


1 581


1 355

Net income
Million SEK		Released
Forecast
Spread 		543
909
-40.23%		258
211
22.49%		451
418
8.01%		1 386
1 303
6.36%		1 067
825
29.36%		222
244
-9.04%		94,0
192
-50.92%		1 026
1 308
-21.53%		800
644
24.19%
180


734


1 565


1 249


1 071

EPS
SEK		Released
Forecast
Spread 		1,83
3,28
-44.21%		0,86
0,73
17.21%		1,51
1,36
10.96%		4,64
4,41
5.19%		3,56
2,79
27.8%		0,74
1,07
-30.52%		0,30
0,45
-33.96%		2,99
3,98
-24.86%		2,33
1,76
32.33%
0,58


1,98


5,46


3,53


3,03

Announcement Date28/04/2219/07/2227/10/2208/02/2327/04/2318/07/2330/10/2308/02/2425/04/24-----

Upcoming sector events for SWEDISH ORPHAN BIOVITRUM

11/07/2024 07:00 BONESUPPORT HOLDING AB: Q2 2024 Earnings Release
15/07/2024 SWEDISH ORPHAN BIOVITRUM AB: Q2 2024 Earnings Release
22/07/2024 BIOGEN INC.: Q2 2024 Earnings Release (Projected)
23/07/2024 07:00 BIOGAIA AB: Q2 2024 Earnings Release
23/07/2024 SAMSUNG BIOLOGICS CO.,LTD.: Q2 2024 Earnings Release (Projected)
24/07/2024 PHARMA MAR, S.A.: Q2 2024 Earnings Release (Projected)
24/07/2024 GRIFOLS, S.A.: Q2 2024 Earnings Release (Projected)
25/07/2024 06:00 UCB: Q2 2024 Earnings Release
25/07/2024 SK BIOSCIENCE CO.,LTD.: Q2 2024 Earnings Release (Projected)
29/07/2024 BIOMARIN PHARMACEUTICAL INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for SWEDISH ORPHAN BIOVITRUM

23/05/2024 10:43 CONCORD BIOTECH LIMITED: Q4 2024 Earnings Release
14/05/2024 16:35 GRIFOLS, S.A.: Q1 2024 Earnings Release
13/05/2024 NATURECELL CO.,LTD.: Q1 2024 Earnings Release
09/05/2024 PHARMARESEARCH CO., LTD.: Q1 2024 Earnings Release
09/05/2024 MEDY-TOX INC.: Q1 2024 Earnings Release
09/05/2024 21:05 AVIDITY BIOSCIENCES, INC.: Q1 2024 Earnings Release
09/05/2024 21:05 ADMA BIOLOGICS, INC.: Q1 2024 Earnings Release
09/05/2024 07:30 NXERA PHARMA CO., LTD.: Q1 2024 Earnings Release
08/05/2024 HUGEL, INC.: Q1 2024 Earnings Release
08/05/2024 21:16 CATALYST PHARMACEUTICALS, INC.: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. SOBI Stock
  4. 0GY1 Stock
  5. Calendar SWEDISH ORPHAN BIOVITRUM